JOURNAL ARTICLE
To Tweet or Not to Tweet: Tweets About Tobacco Regulation can Help Disseminate Anti-regulatory Messages.
Published In: Nicotine & Tobacco Research, 2023, v. 25, n. 9. P. 1603 1 of 3
Database: Academic Search Ultimate 2 of 3
Authored By: Silver, Nathan A; Pearson, George; Kucherlapaty, Padmini; Kalla, Swetha; Schillo, Barbara 3 of 3
Abstract
This article examines how the U.S. Food and Drug Administration's (FDA) use of Twitter to communicate about the Premarket Tobacco Product Application (PMTA) process for e-cigarettes led to disproportionate amplification of anti-policy sentiment. Analyzing 52 FDA tweets and their 711 replies and 155 quote tweets from July to November 2021, the study found that 96.7% of replies and 77.9% of quote tweets opposed the PMTA policy, with anti-policy content receiving significantly more likes and retweets than pro-policy messages. The research highlights how Twitter's interactive features, especially quote tweets, enable opponents to repurpose FDA messages into persuasive counterarguments based on Inoculation Theory, thereby undermining regulatory communication efforts. The findings suggest that public health organizations should carefully consider the risks of engaging on Twitter and develop strategies to monitor and respond to hostile counter-messaging to better support tobacco control objectives.
Additional Information
- Source:Nicotine & Tobacco Research. 2023/09, Vol. 25, Issue 9, p1603
- Document Type:Article
- Subject Area:Computer Science
- Publication Date:2023
- ISSN:1462-2203
- DOI:10.1093/ntr/ntad078
- Accession Number:170020600
- Copyright Statement:Copyright of Nicotine & Tobacco Research is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Looking to go deeper into this topic? Look for more articles on EBSCOhost.